Molbio IPO: Should investors subscribe?
· thehindubusinessline.com
Molbio's IPO presents a growth opportunity for investors, but high valuations may pose risks amid strong market competition.
Molbio is a point-of-care technology (POCT) diagnostics company whose IPO is open from August 10-12. The company developed Truenat, a POCT polymerase chain reac...